Shana is a first-year student in the Clinical Pharmacy Translational Science program. She is currently studying under the precision pharmacotherapy track. Her work investigates genomic ancestry and social factors that may influence clinical outcomes of a diverse group of heart failure patients taking angiotensin inhibitors. Shana’s goal is to become an independent investigator focused on pharmacogenomic implementation. Throughout her learning experiences at U-M, Shana achieved success in personalized medicine and treatment. However, many promising discoveries are not always translated into clinical practice. Her goal is to bridge this gap with her education in pharmacogenomics and interests in implementation in order to provide timely delivery of the most effective treatments to patients.